Scanbio Denmark ApS: Financial statements 2023
CVR: 42107654
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Scanbio Denmark ApS (CVR 42107654) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 11,150,985 and a net result of DKK 4,013,557 compared with DKK 3,884,563 the year before. That is an increase of 38.3% compared with the year before. Equity in the 2023 report amounted to DKK 8,385,802. The solvency ratio was 33.7%. The company had 4 employees in the financial year.
- Gross Profit
- DKK 11,150,985
- Profit/Loss
- DKK 4,013,557
- Equity
- DKK 8,385,802
- Total Assets
- DKK 24,907,567
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 11.2 mio. | 4 mio. | 8.4 mio. | 4 |
| 2022 | - | 8.1 mio. | 3.9 mio. | 4.4 mio. | 4 |
| 2021 | - | 2.5 mio. | 448 t. | 488 t. | 3 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Scanbio Denmark ApS has published its annual report for 2022. Gross profit came to DKK 8,062,158, and the net result was DKK 3,884,563.
About Scanbio Denmark ApS
Scanbio Denmark ApS is a Danish company of the type Anpartsselskab based in Nexø, founded in 2021. The company is registered under the industry Forarbejdning og konservering af fisk, krebsdyr og bløddyr, undtagen fiskemel. The management consists of Tor Vikenes. The company is owned by Scanbio Ingredients AS. According to the 2025 annual report, the company had an average of 6 employees. In 2025, the company reported a gross profit of DKK 5,295,465 and a net result of DKK -135,927 compared with DKK 1,999,265 the year before. Equity in the 2025 report amounted to DKK 10,249,140.